Blood Component Recalls and Market Withdrawals: Frequency, Reasons, and Management in the United States
- 1 February 2013
- journal article
- review article
- Published by Elsevier BV in Transfusion Medicine Reviews
- Vol. 27 (2), 82-90
- https://doi.org/10.1016/j.tmrv.2012.11.001
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto RicoTransfusion, 2012
- Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission (CME)Transfusion, 2012
- Deconstructing the risk for malaria in United States donors deferred for travel to MexicoTransfusion, 2011
- Transfusion-TransmittedBabesiaspp.: Bull's-Eye onBabesia microtiClinical Microbiology Reviews, 2011
- Re: Han JY, Choi JS, Chun JM, Park HD, Lee SY, Kim CH et al. 2009. Pregnancy outcome of women transfused during pregnancy with blood products inadvertently obtained from donors treated with acitretin. Journal of Obstetric and Gynaecology 29:694–697Journal of Obstetrics and Gynaecology, 2010
- Pregnancy outcome of women transfused during pregnancy with blood products inadvertently obtained from donors treated with acitretinJournal of Obstetrics and Gynaecology, 2009
- Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusionsTransfusion, 2008
- The social psychology of amateur ethicists: blood product recall notification and the value of reflexivityJournal of Medical Ethics, 2008
- Understanding the meaning of permanent deferral for blood donorsTransfusion, 2007
- The donor notification process from the donor's perspectiveTransfusion, 2004